Actively Recruiting
A Prospective Observational Study of Foam Sclerotherapy .
Led by Mayo Clinic · Updated on 2026-01-26
100
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
An observational prospective study to determine the impact of foam sclerotherapy of large, dominant kidney/liver cysts on quality of life outcomes and kidney/liver cyst volumes at up to 12 months of follow-up in patients with autosomal dominant polycystic kidney disease (ADPKD) and autosomal dominant polycystic liver disease (ADPLD).
CONDITIONS
Official Title
A Prospective Observational Study of Foam Sclerotherapy .
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 6518 years
- Clinical diagnosis of ADPKD or ADPLD
- 1-3 large, non-exophytic liver or kidney cyst
- Compressive symptoms from dominant cyst
You will not qualify if you...
- Age <18 years
- No diagnosis of ADPKD or ADPLD
- Largest cyst smaller than 4 cm in all dimensions or volume less than 400 cc
- More than 3 large, non-exophytic cysts 654 cm in all dimensions (volume 65400 cc)
- Unwilling to comply with follow-up visits for 12 �B1 1 months after treatment
- Unable to provide informed consent for foam sclerotherapy
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
C
Cassie Howe, CRC
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here